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Supervised exercise rehabilitation in survivors of critical illness: a randomised 
controlled trial 
Abstract 
Objectives:  To investigate the impact of a six week supervised exercise 
programme on cardiopulmonary fitness, balance, muscle strength and anxiety and 
depression in patients who have been discharged home from hospital following an 
intensive care unit (ICU) length of stay of greater than 48 hours. To investigate 
patients’ perceptions of a six week supervised exercise programme delivered at 
three months post hospital discharge.    
Design: A single centre parallel, randomised controlled trial  
Setting: Outpatient department of a university teaching hospital in the UK  
Participants: 60 adult survivors of critical illness, at three months post-hospital 
discharge.  
Intervention: A six week individually prescribed and supervised exercise program, 
with associated advice to home exercise modification. Twice weekly exercise 
sessions were individualised to participant’s functional status and included 
cardiopulmonary, balance and strengthening exercises. Follow up at seven weeks, 
six months and 12 months. 
Outcome measures: Six-Minute Walk Test, BERG balance test, grip strength and 
Hospital Anxiety and Depression Scale. A pre-designed survey was used to explore 
patient perceptions of the programme 
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Results: 62 participants (n=30 received allocated programme in both control and 
treatment groups) were randomised. Loss to follow up resulted in n=34 participants 
for intention to treat analysis at 12 months follow up (leaving n=19 in control group, 
n=15 in treatment group). Median participant age at enrolment was 62 years (IQR: 
49-72), with a median ICU length of stay of 9 days (IQR: 4-17). No significant 
differences were found for the Six-Minute Walk Test at any time point (p>0.05). 
Anxiety levels and balance were significantly improved in the treatment group at 12 
months (p=0.006 and p=0.040 respectively).    
Conclusions: Further research is needed into appropriate interventions and 
outcome measures, target patient populations and timing of such intervention post-
hospital discharge. 
Trial registration: ISRCTN database (ISRCTN11853373,  
Keywords: Critical illness; Rehabilitation; Physical fitness 
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Supervised exercise rehabilitation in survivors of critical illness: a randomised 
controlled trial 
The number of admissions to critical care units in the UK has increased, with 
approximately 163,900 adults affected per year.1 While patient survival rates are 
improving, it is well-recognised that survivors of critical illness experience a range of 
profound physical and functional deficits that can persist for a number of years 
following hospital discharge.2-6 As described by Herridge (2011), extensive research 
has consistently demonstrated the diversity of both physical and neuropsychological 
disabilities sustained by patients following critical illness.7 Risk factors for skeletal 
muscle wasting and weakness include immobility, severity of illness and multi-organ 
failure.8 These physical sequelae add to the burden of illness for not only the 
survivors and their families, but also the health care system.  
The Rehabilitation after Critical Illness in Adults Guidelines published by National 
Institute for Health and Care Excellence (NICE) in 20099 has led to a number of 
studies investigating the impact of exercise in the post-hospital discharge phase.10-18 
The general aim of post-ICU exercise-based rehabilitation is to address the effects of 
the physical deficits experienced by survivors of critical illness, through the delivery 
of a pre-designed exercise programme, that is progressed according to participant 
response to exercise. These exercise programmes may be delivered on an individual 
or group basis and may target different components of physical fitness. It has been 
suggested that there may also be additional psychological and cognitive benefits 
gained from such exercise programmes.11,14,17,18  
In a recent Cochrane review by Connolly et al (2015), it was concluded that it was 
not possible to determine an overall effect on functional exercise capacity using an 
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exercise-based intervention initiated post-ICU discharge for survivors of critical 
illness.19 Reasons included differences in outcome measures used in the studies, 
how the results were reported, lack of detail reported regarding usual care in the 
control groups and overall heterogeneity in study populations.19  Further conclusions 
stated that no study had included an evaluation of acceptance of the treatment by 
patients or the experience of the patient participation in the exercise programme, 
providing the justification for the inclusion of a qualitative component in this trial.19 A 
qualitative investigation may provide some answers as to the lack of reported effect 
in functional status with rehabilitation in this patient cohort.   
The first aim of this study was to investigate the impact of a six week supervised 
exercise programme on cardiopulmonary fitness in patients who have been 
discharged home from hospital following an intensive care unit (ICU) length of stay of 
greater than 48 hours. The second aim was to investigate the impact of a six week 
supervised exercise programme on balance, muscle strength, anxiety and 
depression levels in patients who have been discharged home from hospital 
following an ICU length of stay of greater than 48 hours. The final aim was to explore 
participants’ perceptions of the exercise programme. 
Materials and methods 
Ethical approval for this trial was obtained from the Wales Research Ethics 
Committee 6 and informed written consent was obtained from each patient prior to 
trial enrolment. The trial was registered on the ISRCTN database 
(ISRCTN11853373, Retrospectively registered 07/02/2012 due to lack of study 
funding. First patient recruited 01/11/2011). 
https://www.isrctn.com/ISRCTN11853373?q=epic   
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We conducted a single-centre, assessor-blinded, parallel group, randomised 
controlled trial in a large teaching hospital in Wales. All participants recruited had 
been a patient on the medical and surgical ICU (with paediatric, burns and cardiac 
being managed on separate units and therefore excluded from the trial) for a length 
of stay of 48 hours or more. Exclusion criteria included participants aged less than 
18 years (no upper age limit), living outside of a commutable area (as expressed by 
the participant during the recruitment process), any medical contraindications 
(defined a priori and confirmed by the consultant running the follow up clinic during 
recruitment) to exercise and participation in any other concurrent rehabilitation 
programme.  
The intervention investigated in this trial was a six week, individualised, supervised 
exercise programme. Cardiopulmonary exercises included using the cycle 
ergometers (upper and lower limb as appropriate), treadmill, rowing and stepping 
machines. Specialist bariatric equipment was used for participants with a high body 
mass index. Strengthening exercises were progressed from global exercises using 
functional type activities such as sit to stand or step up exercises to more specific 
muscle strengthening using hand held weights, theraband and weighted balls. The 
larger upper limb (deltoids, biceps and triceps) and lower limb (quadriceps, gluteals, 
hamstrings and calves) muscle groups were targeted with strengthening exercises. 
Balance exercises were also progressed from global, functional exercises in sitting / 
standing through to more advanced exercises using wobble boards and gym balls.  
The intervention was individualised and graded to each patient based on results of 
baseline. For example, if a patient’s greatest limitation on baseline testing was 
evident on the six minute walk test, then the emphasis in the exercise programme 
would be placed on cardiopulmonary exercise. Intensity and duration of all exercises 
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were increased incrementally according to individual patient progression over the six 
week period. All exercises were progressed during the six weeks according to 
individual patient ability, rather than a pre-designed protocol for progression, 
according to number of sets or repetitions. 
Over the course of the trial period, two therapists (physiotherapy technicians, both 
with over five years’ experience of exercise prescription, able to access senior 
qualified physiotherapy staff for advice as required) delivered the sessions; each 
participant had a single therapist responsible for their program prescription and 
progression. Participants were seen on an individual basis (rather than as a group), 
due to the complexity and heterogeneity of the patient cohort. Attendance and 
reasons for non-compliance were recorded. Participants in the exercise group were 
also advised on completing an additional home exercise session, based on their 
personalised programme. The participants in the exercise group would attend the 
physiotherapy outpatient gym (starting within one week from recruitment) for two 
sessions of up to one hour (according to exercise capacity), twice a week, for six 
consecutive weeks. Sessions were delivered on a one to one basis, which often 
proved difficult due to the intensive use of resources needed to achieve this.  
The control group participants received usual care. Outpatient classes or community 
based exercise programmes are not routinely offered to survivors of critical care, so 
usual care involves no formal intervention for these patients. Any patient participating 
in a concurrent formal exercise programme such as pulmonary or cardiac 
rehabilitation were excluded from the trial. Participants were not excluded if they 
exercised on their own volition.  
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The primary outcome measure used was the Six-Minute Walk Test in order to 
evaluate cardiopulmonary fitness.20 This test was selected as it is commonly used as 
a test of physical function in critically ill patients, from ICU stay through to an 
outpatient setting. The test was completed on a flat 10 metre track, with a chair at 
one end in case the participant needed a rest, using standardised instructions for 
completion. This method of completing the test was used throughout the trial. 
Secondary outcome measures used to test balance, grip strength and anxiety and 
depression included the Berg Balance score21, the Jamar Dynamometer (to measure 
grip strength using the ASHT protocol22) and the Hospital Anxiety and Depression 
Scale respectively.  
Baseline measurements (at week one) were recorded following recruitment and 
consent in the ICU Follow-up Clinic. Measurements were then repeated at seven 
weeks (completed in the next appointment, immediately following the final exercise 
session), six months and 12 months. Organisational outcomes, such as adherence 
to the programme, withdrawal, loss to follow-up and adverse events (decided a priori 
and including on-set of acute illness or injuries sustained during exercise) were also 
recorded and analysed. 
At the end of the 12 month period, the exercise group were asked to complete a 
short pre-designed survey. Due to the lack of a validated survey for this patient 
group, we designed and piloted a new survey on two trial patient representatives and 
adapted according it to their feedback, prior to use in the trial. Seven closed, multiple 
choice style questions were included (as presented in the results) that explored the 
patients’ perceptions of the exercise sessions.  
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Sample size was calculated using data collected from our earlier pilot study 
(completed in authors’ hospital in 2009 and 2010 by the same research team) in 
which 24 post ICU patients completed the six minute walk test (6MWT) pre and post 
a six week supervised exercise programme.23 The mean improvement in the six 
minute walk test was 128m (SD: 78m). For this study, we used a conservative 
estimate of the smallest medically relevant difference of 60m, to calculate the 
standardised difference, (giving 0.76) which resulted in a suggested total sample 
size of approximately 60, with a Type II error rate of 0.20 (80% power).  
Consecutive eligible patients were recruited from our ICU Follow-up clinic to the trial 
at 12 weeks post-hospital discharge. Participants were randomly assigned to either 
exercise or control group using a stratification method (Minim software) which 
ensured the groups were evenly matched. The three stratification factors were 
gender, age (18-64 versus 65 years or more) and APACHE II score (1-19 versus 20 
or more). The allocation sequence was held by an independent administration staff 
member (not involved in the study) who kept the allocation concealed from the 
investigators until the baseline measurements had been completed however formal 
blinding was not possible.    
Primary and secondary outcomes were analysed and presented as descriptive data 
(medians / interquartile ranges for non-normal distributions).  Data were analysed 
using a 2-way repeated measures analysis of covariance (MANCOVA) in order to 
present results over time and between groups. Outcome measures were analysed 
using a general linear mixed model with group (control versus treatment) and time 
(treated as categorical levels at baseline, week 7, 6 months and 12 months). 
Covariates (selected a priori) included in the model were ICU length of stay and 
number of pre-existing co-morbidities (both included as continuous variables). Linear 
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mixed models used all outcome data available at each time point therefore 
imputation of missing data was not required. Intention-to-treat analysis was 
conducted for each of the outcomes measures, comparing exercise and control 
group results over each of the time points.  
Organisational outcomes were presented as n(%) and comparisons between the two 
groups analysed using Fisher’s Exact test. Responses from the closed questions in 
the survey results were analysed using descriptive statistics (numbers / 
percentages). All statistical analysis was completed using SPSS (version 23) and 
statistical significance was set at p<0.05 for this trial.  
Results 
Participant flow and characteristics 
Of the 82 patients not meeting the exclusion criteria, 36 lived outside of a 
commutable area, 32 were not considered medically stable for participation and 14 
were already participating in other rehabilitation programmes. The pre-determined 
sample size of 60 patients was achieved (n=30 in each group), however, of the total 
trial cohort, only 34 (57%) participants completed all testing to 12 months. 
Participants were recruited from November 2011 until March 2015, with final 12 
month testing completed in March 2016. Participant flow through the trial is outlined 
in Figure 1, including loss to follow up and withdrawals. 
Figure 1: Flow of patients through trial 
Median participant age at enrolment was 62 years (IQR: 49-72), with a median ICU 
length of stay of 9 days (IQR: 4-17). Only 4 of 60 (7%) patients were not 
mechanically ventilated during their ICU stay and median APACHE II score was 14 
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(IQR: 11-19). An overall mortality rate of n=5 / 60 patients (58%) was reported for the 
trial participants. The only differences between the groups were the number of 
mechanical ventilation days and overall hospital length of stay, which were 
significantly higher in the exercise group (p<0.05) (Table 1). 
Table 1: Characteristics of trial participants 
Both control and intervention groups improved in all outcome measures between 
baseline and 12 months however the substantial level of variability in participants’ 
results is reflected by the large standard deviations (Table 2).   
Table 2: Six-minute walk test, Berg Balance, HAD scale, Grip dynamometer 
test raw data by study group 
Comparison between treatment and control  
There were no significant differences in the Six-Minute Walk Test between control 
and treatment groups at all time-points, and the confidence intervals are very wide 
as a result of the small sample size. There were also no significant differences within 
either group (Table 3)  
Table 3. Group comparisons for Six-Minute Walk Test, using model estimates 
Anxiety levels were significantly lower in the treatment group than the control group 
at seven weeks, which was not maintained at six months, but evident again at 12 
months (Table 4).  Balance was also significantly improved at 12 months in the 
treatment group compared to the control group, but not at any preceding time points 
(Table 4). Results of the MANCOVA analysis highlighted no significant differences in 
the results over time between the two groups (Table 4).   
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Table 4: Group comparisons for all secondary outcome measures from the 
model estimates 
A significant difference was reported between the two groups in mean change from 
baseline in the Six-Minute Walk Test at week 7 and six months, balance at 6 and 12 
months and grip strength at week 7 (Table 5).  
Table 5. Group comparisons for mean change from baseline and effect size 
Organisational outcomes 
Organisational outcomes were analysed and there were no significant differences 
between the two groups in terms of loss to follow up, withdrawal or adverse events. 
There were no adverse events reported during the trial period. Adherence (defined 
as number of patients completing all exercise sessions within the intervention as 
described in trial protocol (but still completing the outcome measures at 7 weeks) 
was 67% in the treatment group. In terms of withdrawal (defined as participant 
withdrawal following randomisation before, or during receipt of the intervention), two 
participants (6%) withdrew from the exercise programme prematurely due to medical 
reasons and three (10%) withdrew as they were returning to work. Total percentage 
attrition rate at 12 months in the exercise group was 50% (15 / 30) and 63% (19/30) 
in the control group. Of the withdrawals, one participant withdrew prior to starting the 
intervention, two participants completed 50% of sessions and two participants 
completed 83% of sessions.  
Exercise programme perceptions 
Results from the seven survey items were that participants felt that six weeks wasn’t 
enough sessions (47%), but that sessions were delivered at an appropriate time post 
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-illness (80%), at the correct intensity (80%), weekly frequency (87%), session 
duration (87%) and number of fitness test sessions (87%); accordingly participants 
would recommend to the programme to other ICU survivors (100%). 
Discussion 
This study of a six week supervised, personalised exercise programme in survivors 
of critical illness, demonstrated no significant difference between the control and 
treatment group in the primary outcome measure of the Six-Minute Walk Test. 
Further information about the patients’ trajectory of illness pre-ICU admission is 
needed to draw any definitive conclusions.  
These results support previous research, which although demonstrating 
improvements in physical function, reported no significant improvement in Six-Minute 
Walk Test when compared to control at 12 months follow up.11,15 The results may be 
due to the loss to follow-up in the study, resulting in the target sample size not being 
achieved at later time points. Similar lack of significant results have been 
demonstrated using other outcome measure of physical function, including anaerobic 
threshold14 and the Rivermead Mobility Index.12,13 
In a later secondary analysis of the Six-Minute Walk Test data obtained in the study 
by Denehy et al (2013)15, the authors reported that in future trials of interventions to 
improve outcomes in critical illness survivors, presence of pre-existing disease 
should be used as a stratification variable and that data should be analysed using 
percentage differences.25 These suggestions for rehabilitation trials, may explain why 
the results of this study were non-significant. Another possible explanation for the 
lack of significant findings in physical function in this study could be that the patients 
in the treatment group were receiving mechanical ventilation for a significantly longer 
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time and had a longer overall hospital length of stay, than the control group. This 
may account for the lower physical function (as evident in Six-Minute Walk Test and 
group strength) recorded at baseline in the treatment group, although this was not 
significant.   
The secondary outcome measures in this study that were found to be significantly 
improved at 12 months from baseline, compared to the control group, were anxiety 
and balance. The 95% Confidence Intervals were narrower for the secondary 
outcome measures than the Six-Minute Walk Test, suggesting a lesser degree of 
variation in results and less impact of the small sample size. Balance is a variable 
that hasn’t been previously investigated in this patient population and may well be 
worthy of further consideration in future studies. Poor balance in this patient cohort 
may be due to loss of neuromuscular control, commonly reported in critically ill 
patients. It could be suggested that this supports more recent research, which 
suggests that further work is needed investigating the most appropriate outcome 
measures for this very heterogeneous patient population.  
Improved levels of anxiety in this study may have been influenced by the use of a 
one to one supervised exercise programme. Participants reported that attending the 
sessions gave them much improved confidence in leaving their homes and even for 
some, returning to work, which may have influenced the withdrawal rate of the 
treatment group. Although feedback about the intervention was very positive, as 
outlined in the survey results, capturing this described benefit as an outcome 
measure is complex. The survey results of this study demonstrated that overall, 
patients were very satisfied with the intervention. It could be suggested that in future 
studies, there is more focus on qualitative outcome measures however alternative 
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methods for exploring patients’ perceptions should be considered. For example the 
use of interviews or focus groups could provide richer data.     
There were a number of limitations that may have influenced the results of this study. 
These limitations have been recognised through recent research, which were 
unknown at the time of trial design. We are unable to report the training intensity 
achieved in each session, by each participant, which may influence the repeatability 
of the trial. Timing of implementation of the treatment may have influenced the trial 
results. The sample size calculation did not sufficiently allow for loss to follow up. As 
a result, as with many previous studies, the results lack significance, despite a trend 
towards greater improvements in the primary outcome in the treatment group, 
compared to control. In future studies, it could be suggested that the clinical 
significance should be considered in the analysis, rather than purely statistical 
significance. The patients only needed to be on ICU for greater than 48 hours for 
inclusion in the study, which is now also known to be insufficient time for this sort of 
trial. Lack of information regarding number of patients with ICU-acquired weakness 
in the sample is another limitation, as this may have provided greater understanding 
as to the lack of difference in baseline outcome measures, despite the longer ICU 
stay and MV days in the treatment group.   
Those patients who returned to work (although only a small number in this trial) may 
influence the trial results and further research investigating the optimal timing for a 
post-ICU rehabilitation programme is needed. The patients were enrolled into the 
study from an ICU follow up clinic, which may have led to the low adherence level to 
the exercise and a biased sample, as not all patients would have attended the clinic. 
ICU survivors that didn’t attend follow up in the first place may be at extremes of 
good function so felt no need to attend, or conversely they may have very poor 
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function, so were unable to travel to the clinic. Furthermore, if the clinic could not be 
held, recruitment was inevitably halted. It could be suggested that patients who felt 
they had no issues since leaving hospital, may have been less inclined to attend, 
than those feeling they had longer-term problems, requiring the attention of the clinic.  
Another limitation of the study is that participants were not asked to keep a record of 
the one exercise session that they were given to complete at home. It is not possible 
to comment therefore of the possible influence of that session or whether 
participants adhered to it. It was also not possible to formally blind participants or 
clinicians to group randomisation, however we attempted to minimise bias by 
blinding the assessor of outcomes. The choice of outcome measures used in this 
study may have missed other clinically important effects that may have been 
captured with alternative measures.  
The time-point post-discharge at which patients were asked to attend the ICU 
Follow-up Clinic invariably influenced the time at which the patient commenced 
participation in the study. Although the aim was to enrol participants at 12 weeks 
post-discharge from the Follow-Up Clinic, patients did not always attend 
appointments at exactly 12 weeks. Variation in length of time from hospital discharge 
may have influenced the study’s findings. Choice of stratification variables for the 
randomisation may also have influenced the results of the trial but recent (and future) 
research may inform future trials of more sensitive variables.  
Despite the limitations of this study, further evidence has been added to the ever-
increasing body of research that has highlighted that effectiveness of post-ICU 
rehabilitation programmes is a complex area. More questions are raised than 
answered currently, such as when the programmes should be commenced, who 
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should be targeted, what interventions are most effective, what outcome measures 
should be used and many more. As with previous research, the six week supervised 
exercise programme in this study did not significantly improve physical function, but 
this may be due to the deficit in sample size or a lack of sensitivity in the Six-minute 
walk test. This study did report a significant improvement in anxiety levels and 
balance at 12 months, when compared with the control group. 
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Table 1: Characteristics of trial participants 
 
 
All patients 
N=60 
Treatment 
N=30 
Control 
N=30 
P value 
Male 31 (52%) 15 (50%) 16 (53%) 0.797 
Age 62 (49-72) 61 (49-70) 62.5 (46-70) 0.503 
APACHE II 14 (11-19) 15 (12-19) 13 (9-19) 0.174 
Functional 
Comorbidity Index 
1 (0-2) 1 (0-2) 1 (0-2) 0.741 
ICU LOS 9 (4-17) 12 (5-21) 7 (4-15) 0.082 
MV days 4 (1-12) 5 (2-14) 2 (1-11) 0.019 
Total Hospital LOS 20 (10-30) 23 (15-45) 15 (9-25) 0.046 
Primary diagnosis: 
Surgical 
Respiratory 
Medical 
Trauma 
Neurology 
 
32 (53%) 
15 (25%) 
9 (15%) 
4 (7%) 
2 (3%) 
 
15 (50%) 
9 (30%) 
5 (17%) 
1 (3%) 
1 (3%) 
 
17 (57%) 
6 (20%) 
4 (13%) 
3 (10%) 
1 (3%) 
 
0.796 
0.552 
>0.999 
>0.999 
 
12-month mortality 5 (8%) 4 (13%) 1 (3%) 0.353 
Readmissions 25 (42%) 13 (43%) 12 (40%) >0.999 
Values presented as number (%) and median (IQR). APACHE II: Acute Physiology and Chronic 
Health Evaluation II; LOS: Length of stay; MV: Mechanical ventilation; readmissions: readmissions to 
hospital during the one year follow up period. Fisher’s Exact test used for comparisons    
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Table 2: Six-minute walk test, Berg Balance, HAD scale, Grip dynamometer 
test raw data by study group 
  Baseline 
Control n=30 
Treatment n=30 
Week 7 
Control n=26 
Treatment 
n=26 
6 months 
Control n=21 
Treatment 
n=20 
12 months 
Control n=19 
Treatment 
n=15 
p-value 
  Mean (SD)  Mean (SD)  Mean (SD)  Mean (SD)  
6MWT Control   
 
Treatment  
  269.7 (196.5)     
 
283.5 (203.2)  
283.6 (229.3)    
 
379.3 (207.3) 
 304.8 (213.7)   
 
381.6 (207.9) 
294.7 (250.5)  
 
363.6 (239.9) 
 
0.491 
 
HAD 
(A) 
Control   
 
Treatment  
 10.3 (4.9)                
 
5.4 (4.9)  
 9.3 (3.9)           
 
3.9 (4.0) 
 8.6 (4.5)            
 
4.9 (4.0)  
 8.6 (4.1)            
 
3.7 (3.0)   
 
0.495 
HAD 
(D) 
Control   
 
Treatment 
 8.3 (4.4)                 
 
4.9 (2.8) 
7.8 (4.3)            
 
3.7 (3.0)  
  7.3 (3.3)           
 
4.4 (3.7) 
 7.6 (4.7)            
 
4.0 (3.8) 
 
0.761 
Berg Control   
 
Treatment  
 50.7 (7.0)              
 
52.4 (4.8)  
 50.5 (7.6)       
 
53.4 (6.2) 
49.7 (7.9)         
 
55.1 (1.9)   
 47.2 (11.4)       
 
54.1 (4.4) 
 
0.990 
GRIP 
(L) 
Control   
 
Treatment 
 19.1 (11.9)            
 
16.6 (9.7) 
 19.5 (12.5)      
 
20.7 (11.4) 
  20.5 (14.2)      
 
22.5 (15.6) 
 24.9 (16.2)      
 
20.1 (12.4) 
 
0.283 
GRIP 
(R) 
Control   
 
Treatment  
 20.1 (13.7)           
 
20.4 (11.6) 
 22.1 (14.1)     
 
22.4 (10.3) 
  22.7 (14.2)      
 
27.7 (15.9) 
 24.9 (16.2)      
 
20.1 (12.4) 
 
0.807 
6MWT: Six-minute Walk Test; HAD(A): Hospital Anxiety and Depression Score (Anxiety); HAD(D): 
Hospital Anxiety and Depression Score (Depression); Grip L: Grip strength left; Grip R: Grip strength 
right; n: number; SD: Standard deviation     
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Table 3. Group comparisons for Six-Minute Walk Test, using model estimates 
Time point Control 
Mean 6MWT (SE) 
Treatment 
Mean 6MWT (SE) 
Mean difference from control 
95% CI, p value 
Baseline 249.47 (36.28) 232.7 (31.70) 16.77 (-79.67 to 113.21) 0.854 
7 weeks 276.27 (42.74) 346.81 (33.07) -70.54 (-179.08 to 38.00) 0.112 
6 months 313.29 (45.76) 339.63 (46.32) -26.34 (-158.42 to 105.73) 0.596 
12 months 294.74 (57.46) 344.68 (62.61) -49.94 (-223.71 to 123.63) 0.373 
6MWT: Six-Minute Walk Test; SE= Standard error; CI: Confidence interval; All values in metres. 
Means / comparisons calculated from linear mixed model, using covariates of number of co-
morbidities and ICU length of stay. Repeated measure p value (results of MANCOVA analysis 
showing results over time between groups): p=0.491.  Within group changes over time: control group: 
p=0.452; treatment group: p=0.546. Significance: p<0.05; 
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Table 4. Group comparisons for Six-Minute Walk Test, using model estimates 
Time point Control 
Mean 6MWT (SE) 
Treatment 
Mean 6MWT (SE) 
Mean difference from control 
95% CI, p value 
Baseline 249.47 (36.28) 232.7 (31.70) 16.77 (-79.67 to 113.21) 0.854 
7 weeks 276.27 (42.74) 346.81 (33.07) -70.54 (-179.08 to 38.00) 0.112 
6 months 313.29 (45.76) 339.63 (46.32) -26.34 (-158.42 to 105.73) 0.596 
12 months 294.74 (57.46) 344.68 (62.61) -49.94 (-223.71 to 123.63) 0.373 
6MWT: Six-Minute Walk Test; SE= Standard error; CI: Confidence interval; All values in metres. 
Means / comparisons calculated from linear mixed model, using covariates of number of co-
morbidities and ICU length of stay. Significance: p<0.05;  
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Table 5. Group comparisons for mean change from baseline and effect size 
  CONTROL INTERVENTION MEAN DIFFERENCE  
Outcome 
measure 
Time point Mean change 
(ES*) 
Mean change 
(ES*) 
Difference (95% CI) ES** 
6MWT Week 7 7.3 (0.04) 104.46 (0.60) 97.15 (-134.97 to -59.33)‡ 1.17 
 6 months 36.48 (0.18) 97.05 (0.56) 60.57 (-112.80 to -8.34) ‡ 0.70 
 12 months 25.0 (0.13) 76.07 (0.44) 51.07 (-125.53 to 23.39) 0.48 
HAD (A) Week 7 -0.77 (0.17) -1.27 (0.22) -0.50 (-1.09 to 2.09) 0.18 
 6 months -1.86 (0.41) -0.26 (0.05) 1.6 (-3.86 to 0.63) 0.45 
 12 months 1.63 (0.35) 1.40 (0.25) -0.23 (-3.14 to 2.68) 0.06 
HAD (D) Week 7 -0.54 (0.12) -1.38 (0.31) -0.84 (-0.55 to 2.23) 0.33 
 6 months -1.24 (0.29) --0.42 (0.09) 0.82 (-2.62 to 0.98) 0.30 
 12 months -0.79 (0.18) -0.67 (0.15) 0.12 (-1.98 to 1.74) 0.03 
Berg Week 7 1.15 (0.09) 2.92 (0.38) 1.77 (-5.68 to 2.14) 0.05 
 6 months -1.10 (0.09) 2.37 (0.30) 3.47 (-6.89 to -0.05) ‡ 0.63 
 12 months -3.47 (0.28) 2.07 (0.27) 5.54 (-11.08 to -0.002) ‡ 0.67 
GRIP (R) Week 7 2.35 (0.18) 3.85 (0.33) 1.5 (-4.60 to 61.58) 0.27 
 6 months 3.33 (0.25) 7.11 (0.62) 3.78 (-9.78 to 2.23) 0.40 
 12 months 6.58 (0.50) 4.93 (0.43) -1.65 (-4.65 to 7.95) 0.19 
GRIP (L) Week 7 1.15 (0.10) 4.54 (0.46) 3.39 (-6.23 to -0.55)‡ 0.64 
 6 months 2.05 (0.15) 6.05 (0.52) 4.00 (-9.84 to 1.84) 0.45 
 12 months 5.84 (0.43) 3.33 (0.29) -2.51 (-3.08 to 8.10) 0.27 
6MWT: Six Minute Walk Test.  Values for 6MWT given in metres  
ES*, effect size= mean change from first assessment / SD at first assessment (based on adjusted scores).  
ES**, effect size= (intervention mean change – usual care mean change) / pooled SD for change (based on 
unadjusted scores).  
‡ significant p<0.05; significant differences between groups occur when CI does not cross 0 
Subject numbers the same as reported in Table 2 
To interpret effect size: Small: <0.20, Medium: 0.50; Large: 0.80; Very large: >1.2 (based on work of 
Sawilowsky, 2009)24 
  
 
 
 
 
